Morita T, Kikuchi T, Hara Y, Ishikawa S, Kobayashi Y, Ishiyama S, Tozuka K, Goto K, Nakashima N, Takahashi K
Dept. of Urology, Jichi Medical School, Tochigi, Japan.
Gan To Kagaku Ryoho. 1989 Oct;16(10):3417-22.
Twenty patients with bladder cancer were treated with intra-arterial infusion chemotherapy using CDDP and ADM in combination with [Sar1, Ile8] angiotensin II. A catheter was introduced into internal iliac artery by Seldinger's technique, and 100 mg of CDDP, 50 mg of ADM and 1 mg of [Sar1, Ile8] angiotensin II were infused through the catheter for 40 minutes. CR was observed in 8 of 20 patients. PR in 11 and NC in 1. Therefore, the response rate (CR + PR) was 95% (19/20). Side effects were generally mild and consisted of leukopenia, nausea, vomiting, diarrhea, alopecia, skin pigmentation and headache. Catheter-related complications were not observed. This study demonstrated that intra-arterial infusion chemotherapy with CDDP and ADM in combination with [Sar1, Ile8] angiotensin II was extremely effective in treating patients with bladder cancer.
20例膀胱癌患者接受了顺铂(CDDP)、阿霉素(ADM)联合[Sar1,Ile8]血管紧张素II的动脉内灌注化疗。采用Seldinger技术将导管插入髂内动脉,通过导管注入100mg顺铂、50mg阿霉素和1mg[Sar1,Ile8]血管紧张素II,持续40分钟。20例患者中8例观察到完全缓解(CR),11例部分缓解(PR),1例无变化(NC)。因此,缓解率(CR+PR)为95%(19/20)。副作用一般较轻,包括白细胞减少、恶心、呕吐、腹泻、脱发、皮肤色素沉着和头痛。未观察到与导管相关的并发症。本研究表明,顺铂和阿霉素联合[Sar1,Ile8]血管紧张素II的动脉内灌注化疗在治疗膀胱癌患者方面极其有效。